Zubin J Eapen Selected Research

Zubin J Eapen Research Topics

19	Heart Failure 12/2020 - 06/2012
5	Atrial Fibrillation 01/2015 - 06/2013
2	Myocardial Infarction 01/2021 - 03/2016
2	Pneumonia (Pneumonitis) 03/2016 - 01/2016
2	Diabetes Mellitus 09/2014 - 03/2012
2	Hemorrhage 12/2013 - 06/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Stroke (Strokes) 01/2021
1	ST Elevation Myocardial Infarction 10/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2016
1	Substance-Related Disorders (Drug Abuse) 11/2015
1	Hypertension (High Blood Pressure) 09/2014
1	Vascular Diseases (Vascular Disease) 09/2014
1	Heart Valve Diseases (Valvular Heart Disease) 12/2013
1	Dyspnea (Shortness of Breath) 09/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2012
1	Anemia 03/2012
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 03/2012

4	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2014 - 06/2012
4	Warfarin (Coumadin)FDA LinkGeneric 03/2014 - 12/2013
2	Angiotensin Receptor AntagonistsIBA 02/2016 - 09/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2016 - 09/2013
2	Mineralocorticoid Receptor AntagonistsIBA 01/2015 - 09/2013
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 02/2016
1	Hydralazine (Apresoline)FDA LinkGeneric 02/2016
1	N 556IBA 11/2015
1	LDL CholesterolIBA 09/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2014
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 09/2013
1	Prescription DrugsIBA 09/2013
1	CreatinineIBA 03/2012

7	Therapeutics 01/2021 - 06/2013
5	Patient Readmission 03/2016 - 06/2013
2	Length of Stay 01/2016 - 07/2013
1	Thrombolytic Therapy 10/2016
1	Percutaneous Coronary Intervention 10/2016
1	Transitional Care 01/2016
1	Drug Therapy (Chemotherapy) 11/2015
1	Critical Care (Surgical Intensive Care) 12/2014
1	Contraindications 01/2014